EBV-Specific Anti-PD1 TCR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV-Specific Anti-PD1 TCR-T Cells, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC [Phase 1, Phase 2]